通过纵向单细胞RNA测序揭示接受贝利尤单抗治疗的系统性红斑狼疮患者B淋巴细胞动态变化
对4例韩国SLE患者贝利尤单抗治疗前及治疗后2周、1、3、6、12个月的外周血单个核细胞进行单细胞RNA测序,分析逾73000个细胞中B细胞和浆母细胞亚群的动态变化;浆母细胞持续下降,初始与过渡B细胞先降后升、记忆B细胞先升后降,NR4A1表达在治疗后6个月升高。
要点
- 浆母细胞在贝利尤单抗治疗全程持续下降。
- 初始与过渡B细胞先下降、3个月时回升;记忆B细胞先升、第3个月后下降。
- 初始与记忆B细胞活化通路在第3、6个月下调,NR4A1表达在6个月时升高。
核心结论
- 观察到的B细胞动态变化为理解抗BAFF治疗在SLE患者中的免疫学机制提供了线索,并强调基于免疫特征预测药物反应研究的必要性。
研究设计与样本
- 对4例韩国SLE患者贝利尤单抗治疗前及治疗后2周、1、3、6、12个月的外周血单个核细胞进行纵向单细胞RNA测序,分析逾73000个外周血单个核细胞。
- 另与22例日本SLE患者的bulk转录组数据进行对比分析。
主要发现
- 共鉴定出8个不同的B细胞和浆母细胞亚群并分析其动态变化。
- 初始与过渡B细胞先下降、3个月时回升;记忆B细胞先升、第3个月后下降;浆母细胞在整个治疗期间持续下降。
- 初始与记忆B细胞的B细胞活化通路在第3、6个月下调,并在治疗前4周通过流式细胞术在蛋白水平验证。
- 与22例日本SLE患者bulk转录组数据比较,贝利尤单抗治疗后6个月NR4A1表达升高,提示其限制自身反应性B细胞的作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Unravelling the mechanisms underlying treatment response for targeted therapeutics in systemic lupus erythematosus (SLE) patients is challenging due to the limited understanding of diverse responses of circulating immune cells, particularly B cells. We investigated B lymphocyte dynamics during anti-BAFF treatment, utilizing longitudinal single-cell transcriptome data. METHODS: We conducted single-cell RNA sequencing on peripheral blood mononuclear cells (PBMCs) in four Korean SLE patients before and after belimumab treatment at the following time points: 2 weeks, 1, 3, 6 and 12 months. RESULTS: Analysing over 73 000 PBMCs, we identified eight distinct subsets of B cells and plasmablasts and analysed dynamic changes within these cell subsets: initial declines in naïve and transitional B cells followed by an increase at 3 months, contrasted by an initial increase and subsequent decrease in memory B cells by the third month. Meanwhile, plasmablasts exhibited a consistent decline throughout the treatment. B cell activation pathways, specifically in naïve and memory B cells, were downregulated during the third and sixth months. These findings were validated at the protein level throughout the first 4 weeks of treatment using flow cytometry. Comparative analysis with bulk transcriptome data from 22 Japanese SLE patients showed increased NR4A1 expression 6 months post-belimumab treatment, indicating its role in restricting self-reactive B cells, thereby contributing to the biological responses of anti-BAFF treatment. CONCLUSION: The observed B cell dynamics provided insights into the immunological mechanisms underlying the therapeutic effects of anti-BAFF in SLE patients. Furthermore, it underscores the need for research in predicting drug responses based on immune profiling.
引用
- Bang SY, Joh CS, Itamiya T, et al. Unveiling the dynamics of B lymphocytes in systemic lupus erythematosus patients treated with belimumab through longitudinal single-cell RNA sequencing. Rheumatology (Oxford). 2025. PMID: 39037931. doi:10.1093/rheumatology/keae364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。